
Glaucoma Care in the Age of COVID-19: The Patient Perspective
During the COVID-19 pandemic, statewide shutdowns impacted regularly scheduled eye exams and access to prescription medications, prompting broader concerns about health and safety.
During the COVID-19 pandemic, statewide shutdowns impacted regularly scheduled eye exams and access to prescription medications, prompting broader concerns about health and safety.
Terri Pickering, MD is a glaucoma specialist at Glaucoma Center of San Francisco and clinical instructor at California Pacific Medical Center.
Glaucoma Research Foundation announced a total of $1.2 million in annual research grants to support 12 investigators at prestigious colleges and universities across the United States.
Allergan has announced the approval of DURYSTA™ (bimatoprost implant), the first biodegradable sustained-release implant for the treatment of open-angle glaucoma …
Glaucoma Research Foundation hosted our first annual Glaucoma Patient Summit in San Francisco on March 16, 2019.
“We are thrilled and honored to have Nancy join our Board of Directors.” said — Andrew G. Iwach, MD …
The FDA has approved Rocklatan, a once-daily IOP-lowering eye drop for patients with open-angle glaucoma, Aerie Pharmaceuticals announced in a press release this week.
The published UK study suggests Selective Laser Trabeculoplasty should become the principal method for treating patients with glaucoma.
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
FOR EYECARE PROFESSIONALS
FOR EYECARE PROFESSIONALS
Glaucoma Research Foundation • 251 Post Street, Suite 600 • San Francisco, CA 94108 • 415-986-3162
Send us an email
We are a 501c3 tax-exempt national nonprofit. Our tax ID number is 94-2495035. Our EIN number is 94-2495035.
Copyright 2023 all rights reserved.
Print Subscription
We will mail Gleams anywhere in the United States and Canada, but we do not mail internationally. Please sign up for the email edition if you live outside of the US or Canada.
You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.
E-mail Subscription
You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.